statistically – Page 19 – Communicable Diseases Research

Clinical Characteristics and Outcomes of Patients with Newly Diagnosed De Novo Acute Myeloid Leukemia (AML) during the COVID-19 Pandemic

Conference abstract

Published on 2021-11-242022-10-05
Journal: Blood [Category] 유전자 메커니즘,

Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis

Covid-19 백신의 임상 효능 비교 : 체계적인 검토 및 네트워크 메타 분석

Meta-Analysis

Published on 2021-11-232022-08-31
Journal: Scientific Reports [Category] MERS, meta-analysis, SARS, 임상,

[키워드] Above acute respiratory syndrome Ad26.COV2.S assessment assessment tool Bia BNT162b2 Clinical efficacy clinical trial comparison controlled trials CoronaVac coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccine database Efficacy eight Epidemiology evaluated Factor followed by Gam-COVID-Vac greater highest Intervention leading logistics mRNA mRNA-1273 mRNA-1273 vaccine mRNA-1273 vaccines Network meta-analysis New nine NMA no statistically significant difference pandemic participant Patient performed Phase 3 Prevent Primary outcome Primary outcomes Probability Randomized controlled trial RCT RCTs registration number respiratory risk risk of bia SARS-CoV-2 searched severe COVID-19 severe disease Side effects significantly statistically statistically significant difference symptomatic symptomatic COVID-19 symptomatic disease systematic review the vaccine the vaccines unique Vaccine Vaccines viral infection was tested while
[DOI] 10.1038/s41598-021-02321-z PMC 바로가기 [Article Type] Meta-Analysis

Evaluation of the effect of clinical characteristics and intensive care treatment methods on the mortality of covid-19 patients aged 80 years and older

80 세 이상의 COVID-19 환자의 사망률에 대한 임상 특성 및 집중 치료 치료 방법의 영향 평가

Research

Published on 2021-11-222022-09-10
Journal: BMC Anesthesiology [Category] MERS, SARS, 치료기술,

[키워드] age albumin anti-cytokine Clinical characteristics Clinical features comorbid diseases Computed tomography coronavirus disease Coronavirus disease 2019 COVID-19 pandemic COVID-19 patients CRP Cytokines Effect ferritin Gender hemodiafiltration HFNC High flow nasal cannula ICU treatment IMV Increased increased risk intensive care intensive care treatment intensive care unit Invasive mechanical ventilation investigated Laboratory laboratory findings LDH mean value mechanical ventilation Mortality mortality rate nasal nasal cannula NIMV Non-invasive non-invasive mechanical ventilation non-survivor Older older adult Older adults outcome pandemic Patient PCT plasma plasma therapy Result significantly significantly higher statistically survivor the patient therapy Thoracic Topic treated Treatment two group two groups were assessed
[DOI] 10.1186/s12871-021-01511-6 PMC 바로가기 [Article Type] Research

Clinical and Laboratory Factors in Predicting Mortality Among COVID-19 RT-PCR Positive Patients: A Retrospective Observational Study From a Tertiary Care Center

Internal Medicine

Published on 2021-11-212022-10-31
Journal: Cureus [Category] COVID-19,

[키워드] Acute kidney injury acute respiratory distress acute respiratory distress syndrome [ards] addition age age and sex AKI albumin analyzed Aspartate aminotransferase AST C-reactive protein (CRP Cardiac arrest carried categorical variable cause center clinical clinical and laboratory characteristics co-morbidities co-morbidity complications condition control group coronavirus disease coronavirus disease (COVID-19) Corticosteroids COVID-19 COVID-19 infection CRP D-dimer death diabetes Factor Frequency Gender higher odds hypertensive IL-6 independent risk factor information Intervention laboratory parameter lactate dehydrogenase LDH Lymphocytes lymphopenia mechanically ventilated medical records Monocytes Mortality Mortality predictors multivariable logistic regression nasal neurological Neutrophils non-survivor outcome Oxygen therapy patients with COVID-19 positive COVID-19 Prevent procalcitonin raised Randomly Result retrospective risk factor risk stratification RT-PCR selected serum creatinine severity shown significantly statistically survivor syndrome Tertiary Tocilizumab univariable was collected were expressed were used
[DOI] 10.7759/cureus.19791 PMC 바로가기 [Article Type] Internal Medicine

Analysis of Serological Biomarkers of SARS-CoV-2 Infection in Convalescent Samples From Severe, Moderate and Mild COVID-19 Cases

중증, 중등도 및 경증 COVID-19 사례의 회복기 샘플에서 SARS-CoV-2 감염의 혈청학적 바이오마커 분석

Comparative Study

Published on 2021-11-192022-09-11
Journal: Frontiers in Immunology [Category] MERS, SARS, 바이오마커, 변종, 진단, 치료기술, 치료법,

[키워드] acute respiratory syndrome addition antibodies antibody Antibody binding antibody levels Antibody Response Antibody responses Antibody Units Antigen Asymptomatic asymptomatic infection average BAU binding antibodies binding antibody binding antibody units Biomarker Biomarkers candidate Clinical severity convalescent sera correlated correlates of protection COVID-19 COVID-19 disease COVID-19 immune response COVID-19 pandemic COVID-19 patients Electroporation ELISA epidemiological studies Epidemiological study flow cytometry HCW healthcare worker Humoral immunity identify IgA IgM increasingly International international standard international units Lateral flow test microneutralisation test Mild mild or asymptomatic infections multiplex neutralisation neutralisation assay Neutralising Antibodies neutralising antibody neutralising antibody response Neutralising antibody responses nucleocapsid positive correlation Prevalence protection pseudotyped RBD Re-infection respiratory Sample SARS-CoV-2 SARS-CoV-2 antigen SARS-COV-2 infection SARS-CoV-2 infections SARS-CoV-2 spike SARS-CoV-2-specific IgG Serological biomarkers SEROLOGICAL STUDY seronegative seropositive Severe acute respiratory syndrome Severe acute respiratory syndrome-related coronavirus Severe acute respiratory syndrome-related coronavirus-2 severe COVID-19 patient severe COVID-19 patients severity significantly higher spike statistically to define unit vaccination Vaccine vaccine trial variants of concern Virus neutralisation virus neutralisation assay virus neutralising antibody VoC were expressed WHO WHO guideline WHO International Standard World Health Organisation
[DOI] 10.3389/fimmu.2021.748291 PMC 바로가기 [Article Type] Comparative Study

Real World Utilization of Bamlanivimab at a Rural Community Hospital

Emergency Medicine

Published on 2021-11-192022-10-31
Journal: Cureus [Category] COVID-19,

Religious identity cues increase vaccination intentions and trust in medical experts among American Christians

432

Published on 2021-11-182022-10-29
Journal: Proceedings of the National Academy of Sciences of [Category] COVID-19,

The Prevalence of ‘‘Food Addiction’’ during the COVID-19 Pandemic Measured Using the Yale Food Addiction Scale 2.0 (YFAS 2.0) among the Adult Population of Poland

Article

Published on 2021-11-172022-10-30
Journal: Nutrients [Category] COVID-19, MERS, SARS,

Mental Health of PhD Students at Polish Universities—Before the COVID-19 Outbreak

Article

Published on 2021-11-172022-10-29
Journal: International Journal of Environmental Research an [Category] Coronavirus, MERS, SARS,

[키워드] affected Anxiety COVID-19 DAVID Depression Deterioration disorder dysfunction group identity Insomnia less material men mental health Occurrence PhD students questionnaire reported representation Research statistically stressors student Symptom Symptoms was used women
[DOI] 10.3390/ijerph182212068 PMC 바로가기 [Article Type] Article

Comparison of Interleukin-6 Plasma Concentration in Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Pediatric Sepsis

Pediatrics

Published on 2021-11-152022-10-31
Journal: Frontiers in Pediatrics [Category] COVID-19,

[키워드] Admission analyzed both groups CDC criteria children children with MIS-C Clinical outcome clinical outcomes collected data Concentration COVID-19 Critically ill CRP datasets demographics described diagnosed Diagnosis difference driven by dysregulated immune response elevated excluded female IL-6 IL-6 inhibitor IL-6 level immunodeficiency immunosuppressive individual inflammatory biomarkers intensive care Interleukin-6 (IL-6) International Mechanical MIS-C Mortality much lower no difference no significant difference off-label Older Patient patient data PCT plasma plasma concentration Primary outcome procalcitonin Protein question retrospective cohort study SARS-CoV-2 SARS-COV-2 infection Sepsis septic Septic shock Sex Shock significantly higher Standard therapy statistically subgroup analysis therapy thought Vasoactive Ventilation was done
[DOI] 10.3389/fped.2021.756083 PMC 바로가기 [Article Type] Pediatrics